Reduction in Post-Synaptic Scaffolding PSD-95 and SAP-102 Protein Levels in the Alzheimer Inferior Temporal Cortex is Correlated with Disease Pathology

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2010-09-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2010-100090PMID 20634587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Housekeepers for accurate transcript expression analysis in Alzheimer's disease autopsy brain tissue

  2010cited by this paper
• A novel mutation in the DLG3 gene encoding the synapse-associated protein 102 (SAP102) causes non-syndromic mental retardation

  2010cited by this paper
• DLG3/SAP102 protein expression in malformations of cortical development: a study of human epileptic cortex by tissue microarray.

  2009cited by this paper
• Synaptic removal of diacylglycerol by DGKζ and PSD‐95 regulates dendritic spine maintenance

  2009cited by this paper
• Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice.

  2009cited by this paper
• Synaptic degeneration in Alzheimer’s disease

  2009cited by this paper
• Subunit- and Pathway-Specific Localization of NMDA Receptors and Scaffolding Proteins at Ganglion Cell Synapses in Rat Retina

  2008cited by this paper
• Reduced Expression of the Inhibitory Synapse Scaffolding Protein Gephyrin in Alzheimer's Disease

  2008cited by this paper
• Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development

  2008cited by this paper
• Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction.

  2008cited by this paper
• Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease

  2008cited by this paper
• Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity.

  2008cited by this paper
• Differential interaction of NMDA receptor subtypes with the post‐synaptic density‐95 family of membrane associated guanylate kinase proteins

  2008cited by this paper
• Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction.

  2008cited by this paper
• Differential Changes in Synaptic Proteins in the Alzheimer Frontal Cortex with Marked Increase in PSD-95 Postsynaptic Protein

  2008influential reference
• Amyloid beta peptides and glutamatergic synaptic dysregulation.

  2008cited by this paper
• PSD-95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling

  2008cited by this paper
• Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.

  2008cited by this paper
• Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.

  2008cited by this paper
• Synaptic adhesion molecules and PSD-95.

  2008cited by this paper
• The Expression of NMDA Receptor Subunit mRNA in Human Chronic Alcoholics

  2008cited by this paper
• Lamina-Specific Abnormalities of NMDA Receptor-Associated Postsynaptic Protein Transcripts in the Prefrontal Cortex in Schizophrenia and Bipolar Disorder

  2008cited by this paper
• Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

  2007cited by this paper
• Analysis of multiple exon-skipping mRNA splice variants using SYBR Green real-time RT-PCR.

  2007cited by this paper
• Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.

  2007cited by this paper
• APOE genotype effects on alzheimer’s disease onset and epidemiology

  2007cited by this paper
• Synapse-Associated Protein 102/dlgh3 Couples the NMDA Receptor to Specific Plasticity Pathways and Learning Strategies

  2007cited by this paper
• NMDA receptor surface mobility depends on NR2A-2B subunits

  2006cited by this paper
• Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.

  2006cited by this paper
• Down‐regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease

  2006cited by this paper
• Selective loss of synaptic proteins in Alzheimer's disease: Evidence for an increased severity with APOE ɛ4

  2006cited by this paper
• Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.

  2005cited by this paper
• Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression.

  2005cited by this paper
• The identification and characterization of excitotoxic nerve-endings in Alzheimer disease.

  2004cited by this paper
• Differential expression of N‐methyl‐d‐aspartate receptor NR2 isoforms in Alzheimer's disease

  2004cited by this paper
• Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation.

  2004cited by this paper
• Postsynaptic Density Protein-95 Regulates NMDA Channel Gating and Surface Expression

  2004cited by this paper
• Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

  2004cited by this paper
• Differential Roles of NR2A and NR2B-Containing NMDA Receptors in Cortical Long-Term Potentiation and Long-Term Depression

  2004cited by this paper
• Synaptic Changes in Alzheimer ’ s Disease Increased Amyloid-and Gliosis in Surviving Terminals Is Accompanied by Decreased PSD-95 Fluorescence

  2004cited by this paper
• Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's disease

  2004cited by this paper
• Insights into the ageing mind: a view from cognitive neuroscience

  2004cited by this paper
• Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal.

  2004cited by this paper
• Differential modulation of NR1‐NR2A and NR1‐NR2B subtypes of NMDA receptor by PDZ domain‐containing proteins

  2004cited by this paper
• Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity

  2004cited by this paper
• Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

  2004cited by this paper
• Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder

  2004cited by this paper
• Global analysis of protein expression in yeast

  2003influential reference
• ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes.

  2003cited by this paper
• Synaptic plasticity in animal models of early Alzheimer's disease.

  2003cited by this paper
• Biochemical and molecular studies using human autopsy brain tissue

  2003influential reference
• Statistical Principles in Experimental Design

  2003cited by this paper
• Ubiquitination regulates PSD-95 degradation and AMPA receptor surface expression.

  2003cited by this paper
• Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions

  2002cited by this paper
• Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways

  2002cited by this paper
• Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.

  2001cited by this paper
• Amyotrophic Lateral Sclerosis-linked Glutamate Transporter Mutant Has Impaired Glutamate Clearance Capacity*

  2001cited by this paper
• Interactions of the Low Density Lipoprotein Receptor Gene Family with Cytosolic Adaptor and Scaffold Proteins Suggest Diverse Biological Functions in Cellular Communication and Signal Transduction*

  2000cited by this paper
• A Developmental Change in NMDA Receptor-Associated Proteins at Hippocampal Synapses

  2000cited by this paper
• Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

  2000cited by this paper
• Gene expression in human alcoholism: microarray analysis of frontal cortex.

  2000cited by this paper
• PSD-95 involvement in maturation of excitatory synapses.

  2000cited by this paper
• PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A.

  1999cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease.

  1998cited by this paper
• Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains.

  1996cited by this paper
• Variant Forms of Neuronal Glutamate Transporter Sites in Alzheimer's Disease Cerebral Cortex

  1995cited by this paper
• Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.

  1994cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein.

  1992cited by this paper
• Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease.

  1992cited by this paper
• Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

  1990cited by this paper
• Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain.

  1986influential reference
• Metabolic and functional studies on post-mortem human brain.

  1983influential reference
• Changes in brain weights during the span of human life: Relation of brain weights to body heights and body weights

  1978cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Neurobiology of Disease Soluble ␤-amyloid 1– 40 Induces Nmda-dependent Degradation of Postsynaptic Density-95 at Glutamatergic Synapses

  year unknowncited by this paper

• Synaptic scaffold protein PSD-95: a therapeutic target for Alzheimer's disease.

  2025cites this paper
• From stress to Alzheimer's: A circuit-based framework for prefrontal cognitive dysfunction.

  2025cites this paper
• Resilience mechanisms underlying Alzheimer’s disease

  2025influential citation
• Age-dependent sex differences in cofilin1 pathway (LIMK1/SSH1) and its association with AD biomarkers after chronic systemic inflammation in mice.

  2024cites this paper
• Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis

  2024cites this paper
• Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment

  2024cites this paper
• Role of astrocytes in Alzheimer's disease pathogenesis and the impact of exercise-induced remodeling.

  2024cites this paper
• CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia

  2024cites this paper
• Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease

  2024cites this paper
• MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice

  2023cites this paper
• Synapse-associated protein 102 – a highly mobile MAGUK predominate in early synaptogenesis

  2023cites this paper
• Long-term potentiation-based screening identifies neuronal PYGM as a synaptic plasticity regulator participating in Alzheimer’s disease

  2023cites this paper
• A Systems Pharmacology Approach, Using Molecular Docking and Dynamics Simulation, to Unlock Potential New Therapies for Alzheimer’s Disease: A Case Study of Cinnamon Species

  2023cites this paper
• Neurodegeneration and astrogliosis in the entorhinal cortex in Alzheimer's disease: Stereological layer‐specific assessment and proteomic analysis

  2022cites this paper
• Novel approaches to increase synaptic resilience as potential treatments for Alzheimer's disease.

  2022cites this paper
• Sex differences in GABAA receptor subunit transcript expression are mediated by genotype in subjects with alcohol‐related cirrhosis of the liver

  2022cites this paper
• The role of brain-derived neurotrophic factor and the neurotrophin receptor p75NTR in age-related brain atrophy and the transition to Alzheimer’s disease

  2022cites this paper
• A metabolite attenuates neuroinflammation, synaptic loss and cognitive deficits induced by chronic infection of Toxoplasma gondii

  2022cites this paper
• Phenylethanoid Glycosides of Cistanche Improve Learning and Memory Disorders in APP/PS1 Mice by Regulating Glial Cell Activation and Inhibiting TLR4/NF-κB Signaling Pathway

  2022cites this paper
• Roflumilast, a Phosphodiesterase-4 Inhibitor, Ameliorates Sleep Deprivation-Induced Cognitive Dysfunction in C57BL/6J Mice

  2022cites this paper
• Bioactive Nanoenzyme Reverses Oxidative Damage and Endoplasmic Reticulum Stress in Neurons under Ischemic Stroke.

  2021cites this paper
• Inhibition of PDE4 by Roflumilast ameliorates sleep deprivation-induced cognitive dysfunction in C57BL/6J mice

  2021cites this paper
• Genotype Load Modulates Amyloid Burden and Anxiety-Like Patterns in Male 3xTg-AD Survivors despite Similar Neuro-Immunoendocrine, Synaptic and Cognitive Impairments

  2021cites this paper
• Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model

  2020cites this paper
• Chronic Presence of Oligomeric Aβ Differentially Modulates Spine Parameters in the Hippocampus and Cortex of Mice With Low APP Transgene Expression

  2020cites this paper
• Epigenome signatures landscaped by histone H3K9me3 are associated with the synaptic dysfunction in Alzheimer's disease

  2020cites this paper
• Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease

  2020cites this paper
• Elevated PSD-95 blocks ion-flux independent LTD: a potential new role for PSD-95 in synaptic plasticity.

  2020cites this paper
• Schisandra Extract and Ascorbic Acid Synergistically Enhance Cognition in Mice through Modulation of Mitochondrial Respiration

  2020cites this paper
• Neuroprotective Effects of Chronic Resveratrol Treatment and Exercise Training in the 3xTg-AD Mouse Model of Alzheimer’s Disease

  2020cites this paper
• Glutamine + glutamate level predicts the magnitude of microstructural organization in the gray matter in the healthy elderly

  2019cites this paper
• Ethanol Extract of Centipeda minima Exerts Antioxidant and Neuroprotective Effects via Activation of the Nrf2 Signaling Pathway

  2019cites this paper
• Effects of Transplanted Umbilical Cord Blood Mononuclear Cells Overexpressing GDNF on Spatial Memory and Hippocampal Synaptic Proteins in a Mouse Model of Alzheimer’s Disease

  2019cites this paper
• RPS23RG1 Is Required for Synaptic Integrity and Rescues Alzheimer's Disease-Associated Cognitive Deficits.

  2019cites this paper
• RPS23RG1 is Required for Synaptic Integrity and Rescues Alzheimer’s Associated Cognitive Deficits

  2019cites this paper
• Aberrant DNA methylation of synaptophysin is involved in adrenal cortisol-producing adenoma

  2019cites this paper
• Angiotensin II-mediated suppression of synaptic proteins in mouse hippocampal neuronal HT22 cell was inhibited by propofol: role of calcium signaling pathway

  2018cites this paper
• Dynamic SAP102 expression in the hippocampal subregions of rats and APP/PS1 mice of various ages

  2018influential citation
• Fisetin Reduces the Impact of Aging on Behavior and Physiology in the Rapidly Aging SAMP8 Mouse

  2018cites this paper
• Enhanced cognition and dysregulated hippocampal synaptic physiology in mice with a heterozygous deletion of PSD‐95

  2018cites this paper
• Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model

  2018cites this paper
• Curcumin can influence synaptic dysfunction in APPswe/PS1dE9 mice

  2018cites this paper
• Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer’s Disease Trans-Mitochondrial Cybrid Cells

  2017cites this paper
• Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP/PS1 mice

  2017cites this paper
• Identification of the Role of miR-142-5p in Alzheimer’s Disease by Comparative Bioinformatics and Cellular Analysis

  2017cites this paper
• Human LRRK2 G2019S mutation represses post‐synaptic protein PSD95 and causes cognitive impairment in transgenic mice

  2017cites this paper
• Hypersocial behavior and biological redundancy in mice with reduced expression of PSD95 or PSD93

  2017cites this paper
• Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease

  2017cites this paper
• Glutamate-glutamine and GABA in brain of normal aged and patients with cognitive impairment

  2017cites this paper
• Down‐regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease

  2016cites this paper
• Differential Regulation of N-Methyl-D-Aspartate Receptor Subunits is An Early Event in the Actions of Soluble Amyloid-β1-40 Oligomers on Hippocampal Neurons

  2016cites this paper
• Cerebral dopamine neurotrophic factor alleviates Aβ25-35-induced endoplasmic reticulum stress and early synaptotoxicity in rat hippocampal cells.

  2016cites this paper
• AMPA Receptors as Therapeutic Targets for Neurological Disorders.

  2016cites this paper
• Investigating the mechanisms underlying Alzheimer's disease using a novel organotypic brain slice culture model

  2016cites this paper
• Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression

  2016cites this paper
• Cinnamon Converts Poor Learning Mice to Good Learners: Implications for Memory Improvement

  2016cites this paper
• Age-dependent changes in the glutamate-nitric oxide pathway in the hippocampus of the triple transgenic model of Alzheimer's disease: implications for neurometabolic regulation.

  2016cites this paper
• Altered protein phosphorylation as a resource for potential AD biomarkers

  2016cites this paper
• Deletion of Neurotrophin Signaling through the Glucocorticoid Receptor Pathway Causes Tau Neuropathology

  2016cites this paper
• Synaptic protein levels altered in vascular dementia

  2015cites this paper
• Liver X Receptor Agonist Modifies the DNA Methylation Profile of Synapse and Neurogenesis-Related Genes in the Triple Transgenic Mouse Model of Alzheimer’s Disease

  2015influential citation
• Hsp90 Chaperone Inhibitor 17-AAG Attenuates Aβ-Induced Synaptic Toxicity and Memory Impairment

  2014cites this paper
• Pathological reorganization of NMDA receptors subunits and postsynaptic protein PSD-95 distribution in Alzheimer's disease.

  2014cites this paper
• An investigation into the relationships between synaptic biochemistry, clinical symptoms and pathology in the Lewy body dementias and Alzheimer's disease

  2014cites this paper
• Oligomeric Aβ-induced synaptic dysfunction in

  2014cites this paper
• Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

  2014cites this paper
• Role of membrane-associated guanylate kinases in somatosensory cortical development

  2014cites this paper
• A framework to understand the variations of PSD-95 expression in brain aging and in Alzheimer's disease.

  2014cites this paper
• Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome

  2014cites this paper
• Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease.

  2014cites this paper
• Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain.

  2014cites this paper
• Enhancement of Morphological Plasticity in Hippocampal Neurons by a Physically Modified Saline via Phosphatidylinositol-3 Kinase

  2014cites this paper
• Glutamatergic Transmission Aberration: A Major Cause of Behavioral Deficits in a Murine Model of Down's Syndrome

  2014cites this paper
• Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer’s disease (AD)

  2014cites this paper
• Modulation of behavior by scaffolding proteins of the post-synaptic density.

  2013cites this paper
• Brain-Site-Specific Proteome Changes Induced by Neuronal P60TRP Expression

  2013cites this paper
• Axonal and synaptic pathology in Alzheimer’s disease

  2013cites this paper
• Synaptic Protein α1-Takusan Mitigates Amyloid-β-Induced Synaptic Loss via Interaction with Tau and Postsynaptic Density-95 at Postsynaptic Sites

  2013cites this paper
• Optimizing GluR1 and PSD 95 for slot blot analysis and the neonatal effects on mouse after exposure to ALPi, ZS or TBBPA

  2013cites this paper
• Biological Targeting and Activity of Pre-fibrillar Aβ Assemblies

  2012cites this paper
• Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases

  2012cites this paper
• Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction.

  2012cites this paper
• Arsenite exposure altered the expression of NMDA receptor and postsynaptic signaling proteins in rat hippocampus.

  2012cites this paper
• Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease

  2012cites this paper
• Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.

  2012cites this paper
• Homer-1a immediate early gene expression correlates with better cognitive performance in aging

  2012cites this paper
• MDA receptor / amyloid precursor protein interactions : A comparison between ild-type and amyloid precursor protein mutations associated with familial lzheimer ’ s disease

  2012cites this paper
• Rivastigmine Lowers Aβ and Increases sAPPα Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons

  2011cites this paper
• Oxidative insults to neurons and synapse are prevented by aged garlic extract and S‐allyl‐l‐cysteine treatment in the neuronal culture and APP‐Tg mouse model

  2011cites this paper
• Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease.

  2011influential citation
• Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer’s disease

  2011cites this paper
• Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease

  2011cites this paper